DABNOLIA

Welcome to the Brand page for “DABNOLIA”, which is offered here for Recombinant monoclonal antibodies directed against the rhesus d antigen.

Its status is currently believed to be active. Its class is “Pharmaceuticals”. “DABNOLIA” is believed to be currently owned by “LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES”.

Owner:
LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES
Owner Details
Description:
Recombinant monoclonal antibodies directed against the Rhesus D antigen
Categories: RECOMBINANT MONOCLONAL ANTIBODIES